Literature DB >> 1452489

The site concentrations of antimicrobial agents in the lung.

D Honeybourne1, D R Baldwin.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1452489     DOI： 10.1093/jac/30.3.249

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  15 in total

Review 1.  Review of macrolides and ketolides: focus on respiratory tract infections.

Authors:  G G Zhanel; M Dueck; D J Hoban; L M Vercaigne; J M Embil; A S Gin; J A Karlowsky
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells.

Authors:  M E Cavet; M West; N L Simmons
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

3.  Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin.

Authors:  K B Patel; D Xuan; P R Tessier; J H Russomanno; R Quintiliani; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

4.  Antibiotic penetration into lung tissues.

Authors:  D Honeybourne
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

5.  Concentrations of ampicillin and sulbactam in serum and in various compartments of the respiratory tract of patients.

Authors:  A Wildfeuer; K H Rühle; P L Bölcskei; M Springsklee
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

Review 6.  Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects.

Authors:  Garyphallia Poulakou; Dimitrios K Matthaiou; David P Nicolau; Georgios Siakallis; George Dimopoulos
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

7.  Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin.

Authors:  John E Conte; Jeffrey A Golden; Juliana E Kipps; Emil T Lin; Elisabeth Zurlinden
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Susceptibility of Mycobacterium kansasii to ofloxacin, sparfloxacin, clarithromycin, azithromycin, and fusidic acid.

Authors:  R S Witzig; S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

9.  Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.

Authors:  Florian Tomaselli; Peter Dittrich; Alfred Maier; Michael Woltsche; Veronika Matzi; Johannes Pinter; Stephan Nuhsbaumer; Hans Pinter; Josef Smolle; Freyja M Smolle-Jüttner
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

10.  Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis.

Authors:  Florian Tomaselli; Alfred Maier; Veronika Matzi; Freyja Maria Smolle-Jüttner; Peter Dittrich
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.